Loading data
CLRBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 11.5 m USD | 26.14 m USD | 27.27 m USD | 18.27 m USD | 17.59 m USD |
| Operating profit | -22.98 m USD | -51.78 m USD | -38.96 m USD | -28.81 m USD | -24.13 m USD |
| Profit before tax | -21.79 m USD | -44.52 m USD | -42.83 m USD | -31.85 m USD | -24.12 m USD |
| Income tax expense | — | 66 k USD | -60 k USD | -60 k USD | — |
| Net income (reported basis) | -21.79 m USD | -44.58 m USD | -37.98 m USD | -28.6 m USD | -24.12 m USD |
| Basic earnings per share | -8.35 USD/share | -36.52 USD/share | -3.5 USD/share | -4.51 USD/share | -4.35 USD/share |
| Diluted earnings per share | -8.35 USD/share | -41.89 USD/share | -3.5 USD/share | -4.51 USD/share | -4.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.